Merck & Co. Inc. 4
4 · Merck & Co. Inc. · Filed Dec 8, 2014
Insider Transaction Report
Form 4
Kuhlik Bruce N
Exec. V.P. and General Counsel
Transactions
- Exercise/Conversion
Common Stock
2014-12-08$51.02/sh+50,000$2,551,000→ 178,467.496 total - Sale
Common Stock
2014-12-08$62.00/sh−50,000$3,100,000→ 128,467.496 total - Exercise/Conversion
Stock Option (right to buy)
2014-12-08−50,000→ 0 totalExercise: $51.02From: 2008-08-01Exp: 2017-07-31→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- [F2]Holdings include shares acquired in dividend reinvestment transactions.
- [F3]The option became exercisable in equal installments on 8/1/2008, 8/1/2009 and 8/1/2010.